Effect of Sex Differences in Treatment Response to Angioplasty in a Murine Arteriovenous Fistula Model.
Failure to mature and venous neointimal hyperplasia formation are the two major causes of hemodialysis arteriovenous fistula (AVF) vascular access failure. Percutaneous transluminal angioplasty (PTA) is the first-line treatment for both of these conditions, but clinically, women have decreased patency rates when compared to men. The hypothesis to be tested in the present paper was that female mice after PTA of venous areas of higher intimal thickening have increased gene expression of transforming growth factor-β1 (TGF-β1) and transforming growth factor-β receptor 1 (TGFβ-R1) accompanied with histologic changes of fibrosis when compared to males. Seventeen male and eighteen female C57BL/6J mice were used in this study. Chronic kidney disease (CKD) was induced by partial nephrectomy, and twenty-eight days later, an AVF was created to connect the left carotid artery to the right jugular vein. Two weeks later, higher intimal thickening area was treated with PTA and the mice were sacrificed 3 days later for gene expression analysis or 14 days later for histopathological analysis. Doppler ultrasound was performed weekly after AVF creation. At day 3, female AVF had significantly higher average gene expression of TGF-β1 and TGFβ-R1 compared to male. At day 14, female outflow veins had a smaller venous diameter, lumen vessel area, decreased wall shear stress (WSS), lower average peak systolic velocity and an increased neointima area/media area ratio. Moreover, female outflow veins showed a significant increase in α-smooth muscle cell actin (α-SMA) and fibroblast specific protein-1 (FSP-1). There was a decrease in M1/M2 with an increase in CD68.